Announcement

31 Oct 2014

Cardiff ECMC’s study combining AKT inhibitor AZD5363 with hormone therapy drug fulvestrant has now recruited its first patient, a radiographer from Barry in Wales.

31 Oct 2014

TRACERx is being conducted at six sites, including five Experimental Cancer Medicine Centres: London-UCL, Leicester, Manchester, Aberdeen, Birmingham, and Cardiff.

31 Oct 2014

Did you know support was available for professionals involved in the management of clinical trials data?

05 Nov 2014

The National Lung Matrix Trial is a clinician-led collaborative study between the University of Birmingham, Cancer Research UK, Astra Zeneca and Pfizer.

Pages